VectivBio
VECT
#5948
Rank
โ‚ฌ0.89 B
Marketcap
14,29ย โ‚ฌ
Share price
0.00%
Change (1 day)
173.97%
Change (1 year)

Revenue for VectivBio (VECT)

Revenue in 2022: โ‚ฌ23.19 Million

According to VectivBio's latest financial reports the company's current revenue (TTM ) is โ‚ฌ23.19 Million. In 2022 the company made a revenue of โ‚ฌ23.19 Million an increase over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for VectivBio from 2019 to 2022

Annual revenue

Year Revenue Change
2022โ‚ฌ23.19 M
2021N/A
2020N/A
2019N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Organovo
ONVO
โ‚ฌ0.12 M-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
โ‚ฌ18.52 M-20.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
โ‚ฌ0.86 B 3,646.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
โ‚ฌ0.54 B 2,249.11% Jersey